MAP4K1 and cancer: The first evidence that HPK1 is involved in the second step of cancer-immunity cycle came when it was shown that HPK1-/- bone marrow derived dendritic cells (BMDCs) exhibited elevated levels of CD80 and CD86 in response to receiving maturation signal via LPS stimulation (Alzabin et al., 2009).